p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53

被引:74
作者
Gottlieb, E [1 ]
Oren, M [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
关键词
apoptosis; caspase; interleukin-3; p53; retinoblastoma;
D O I
10.1093/emboj/17.13.3587
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the interleukin-3 (IL-3)-dependent lymphoid cell line DA-1, functional p53 is required for efficient apoptosis in response to IL-3 withdrawal. Activation of p53 in these cells, by either DNA damage or p53 overexpression, results in a vital growth arrest in the presence of IL-3 and in accelerated apoptosis in its absence. Thus, IL-3 can control the choice between p53-dependent cell-cycle arrest and apoptosis, Here we report that the cross-talk between p53 and IL-3 involves joint control of pRb cleavage and degradation. Depletion of IL-3 results in caspase-mediated pRb cleavage, occurring preferentially within cells which express functional p53, Moreover, pRb can be cleaved efficiently by extracts prepared from DA-1 cells but not from their derivatives which lack p53 function. Inactivation of pRb through expression of the human papillomavirus (HPV) E7 oncogene overrides the effect of IL-3 in a p53-dependent manner. Our data suggest a novel role for p53 in the regulation of cell death and a novel mechanism for the cooperation between p53 and survival factor deprivation. Thus, p53 makes cells permissive to pRb cleavage, probably by controlling the potential activity of a pRb-cleaving caspase, whereas IL-3 withdrawal provides signals that turn on this potential activity and lead to the actual cleavage and subsequent degradation of pRb, Elimination of a presumptive anti-apoptotic effect of pRb may then facilitate conversion of p53-mediated growth arrest into apoptosis.
引用
收藏
页码:3587 / 3596
页数:10
相关论文
共 84 条
[1]  
ABRAHAMSON JLA, 1995, MOL CELL BIOL, V15, P6953
[2]   DEFICIENCY OF RETINOBLASTOMA PROTEIN LEADS TO INAPPROPRIATE S-PHASE ENTRY, ACTIVATION OF E2F-RESPONSIVE GENES, AND APOPTOSIS [J].
ALMASAN, A ;
YIN, YX ;
KELLY, RE ;
LEE, EYHP ;
BRADLEY, A ;
LI, WW ;
BERTINO, JR ;
WAHL, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5436-5440
[3]  
An B, 1996, CANCER RES, V56, P438
[4]   Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis [J].
Attardi, LD ;
Lowe, SW ;
Brugarolas, J ;
Jacks, T .
EMBO JOURNAL, 1996, 15 (14) :3693-3701
[5]   p53 in signaling checkpoint arrest or apoptosis [J].
Bates, S ;
Vousden, KH .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (01) :12-18
[6]  
Berry DE, 1996, ONCOGENE, V12, P1809
[7]  
BLANDINO G, 1995, ONCOGENE, V10, P731
[8]   P53-DEPENDENT APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF P53-TARGET GENES [J].
CAELLES, C ;
HELMBERG, A ;
KARIN, M .
NATURE, 1994, 370 (6486) :220-223
[9]  
Canman C E, 1997, Adv Pharmacol, V41, P429, DOI 10.1016/S1054-3589(08)61068-6
[10]   GROWTH-FACTOR MODULATION OF P53-MEDIATED GROWTH ARREST VERSUS APOPTOSIS [J].
CANMAN, CE ;
GILMER, TM ;
COUTTS, SB ;
KASTAN, MB .
GENES & DEVELOPMENT, 1995, 9 (05) :600-611